Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

February 20, 2025

Study Completion Date

February 28, 2025

Conditions
Dengue Fever
Interventions
DRUG

CPLE

It will be a double-blind study,CPLE and Placebo will be marked as either Group A or Group B.Half of the patients will receive Group A and other half will receive Group B drug along with standard treatment according to national guideline,Each participant will receive either CPLE or Placebo,500 mg 2 capsules three times daily for 5 days and will be followed up daily upto study day 5.

DRUG

Placebo

"The patients will be assigned to visually matched placebo 2 capsule t.i.d for 5 days The oral capsule of CPLE and placebo will be provided by the Institute of Technology Transfer and Innovation (ITTI), an institute in Bangladesh Council of Scientific and Industrial Research (BCSIR). On receipt, the medications will be stored in a secure area at room temperature. Enrolled patients will receive CPLE or placebo for 5 days.~Clinical data will be captured on structured case report forms."

Trial Locations (1)

1000

Prof Shohael Mahmud Arafat, Dhaka

All Listed Sponsors
collaborator

Institute of Technology Transfer & Innovation (ITTI)

UNKNOWN

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT06945679 - Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients | Biotech Hunter | Biotech Hunter